Skip to main content
TCMD logo

TCMD · Tactile Systems Technology Inc · Investor Relations

Track TCMD — free
$26.32 -0.10 (-0.38%) Play latest call Q2 2026 earnings call transcript
Market Cap
$598.47M
Shares
22.65M
Volume · Nov 19 4081 Avg daily vol (3M) 256.77K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-12-02 19:30 UTC Piper Sandler 38th Annual Healthcare Conference Conference

Recent news

Date Headline
2026-11-18 Tactile Medical to Participate in the Piper Sandler 38th Annual Healthcare Conference

MINNEAPOLIS, Nov. 18, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in a fireside chat at the Piper

2026-11-02 Tactile Systems Technology, Inc. Reports Third Quarter 2026 Financial Results

MINNEAPOLIS, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the third quarter ended September 30, 2026.

2026-10-19 Tactile Medical to Release Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026

MINNEAPOLIS, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that third quarter of fiscal year 2026 financial results will be

2026-08-10 Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results

MINNEAPOLIS, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the second quarter ended June 30, 2026.

2026-07-21 Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026

MINNEAPOLIS, July 21, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that second quarter of fiscal year 2026 financial results will be

2026-07-13 Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve™ Wearable Compression Device for VA and DoD Patients

Discreet, Battery-Powered Device Reaches Patients at Earlier Stages of Disease Progression MINNEAPOLIS, July 13, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic

2026-06-02 Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy

Reduced Weight, Expanded Size Adjustability, and Built-in Wi-Fi & Bluetooth® Deliver a More Comfortable, Connected Patient Experience Without Compromising Clinical Effectiveness MINNEAPOLIS, June 02, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”)

2026-05-20 Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference

MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the William Blair 46th Annual

2026-05-04 Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results

MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2026.

2026-04-20 Tactile Medical to Release First Quarter of Fiscal Year 2026 Financial Results on May 4, 2026

MINNEAPOLIS, April 20, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2026 financial results will be

2026-03-09 Tactile Medical Strengthens Board of Directors with Appointment of Andrea Pearson

MINNEAPOLIS, March 09, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Andrea Pearson to the Company’s Board of

2026-02-17 Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

MINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the fourth quarter and full year ended December

2026-02-17 Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio

LymphaTech’s 3D Platform and Digital Capabilities to Improve Disease Identification, Accelerate Therapy Adoption, and Support Next-Generation Lymphatic Therapies MINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a

Past events

Source: https://investors.tactilemedical.com/

Key facts CIK 1027838 CUSIP 87357P100 13F (30d) 174 filings 150 filers Visit website Investor relations